For some people, tablets may feel easier to fit into their lifestyle and better suited to their needs, while others may prefer injections or continue seeing strong results with them
& Ritchie, M
The Journal of cell biology 2013;203, 929-942, doi:10.1083/jcb.201306073 28
This makes orforglipron easier to take, says Melanie Jay, MD, a professor at the New York University Grossman School of Medicine and director of the NYU Langone Comprehensive Program on Obesity Research in New York City
Mehdi SF, Pusapati S, Anwar MS, Lohana D, Kumar P, Nandula SA, et al
This study of semaglutide demonstrates the effectiveness of a new pathway to reduce the excess risk associated with obesity of important and potentially deadly cardiovascular complications. One limitation of the trial is that only patients with pre-existing cardiovascular disease were included